Tag: cell & gene therapies

ARM’s Recommendations for Timely Access to ATMPs in Europe

Europe’s leading nations should commit to a rapid overhaul of health technology assessment (HTA) and bold initiatives such as new pan-European real world evidence (RWE) frameworks, in order to nurture...

Thermo Fisher Acquires Brammer Bio for $1.7bn

Thermo Fisher Scientific Inc., the world leader in serving science, and Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, announced they have entered into a definitive a...

Merck and Chinese Company to Focus on C&G Therapy

Collaboration to build global-standard platform for plasmid and virus manufacturing in China. Merck, a leading science and technology company, today announced the signing of a non-binding Memorandu...

Microsoft and Oxford Biomedica in R&D Collaboration

Oxford Biomedica plc, a leading gene and cell therapy group, today announces that it has entered into a research and development collaboration with Microsoft Research to improve the yield and quality ...

WHP to Build Facility for Oxford BioMedica

New state of the art cleanroom facilities will enable a leading international gene and cell therapy company to expand its bioprocessing operations and manufacturing capabilities. Multi-disciplinary e...

Marken to Build New GMP Facility

Marken is expanding its facilities in Philadelphia to include more space for logistics operations as well as a new GMP-compliant storage and distribution center to meet the growing demand for services...

Hitachi Chemical Acquires All apceth Biopharma’s Shares

apceth Biopharma GmbH, a leading contract manufacturing organization in the field of cell and gene therapy, announces that Hitachi Chemical Co., Ltd. will enter into an agreement to acquire all shares...

SGC Invests £7.6m to Expand Testing Capabilities

Clients will benefit from a fully comprehensive range of validated biosafety methods to support cell bank and viral vaccine manufacturing and lot release of drug product. SGS has invested £7.6 mill...

TrakCel and Quick Partner for Cell and Gene Therapies Tracking

On Jan. 17, 2019, TrakCel, a UK-based developer of cell and gene therapy supply-chain tracking and orchestration systems software, and The Quick Life Science Group, a US-based provider of time- and te...

FDA Predicts Rapid Development of Cell and Gene Therapies

A massive upsurge in the development of cell and gene therapies means the FDA expects to receive up to 200 applications to start trials every year from 2020. It also expects to be approving 10 to 2...

GMP-Complied Reagent for Cell & Gene Therapies

Polyplus-transfection® SA, a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction and therapeutics, announces the launch of P...